pharmaphorum

FEBRUARY 4, 2021

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month. The book features insights and recommendations from 40 leading experts in the field, who hope that Italy will begin to follow in the footsteps of early adopters of digital therapeutics such as Germany, France and

Documentation 139

Documentation Communication 139

Pharma Times

FEBRUARY 3, 2021

The data show 100% protection against severe disease, hospitalisation and death, greater vaccine efficacy with an inter-dose interval of 12 weeks or more, and the potential for reduced asymptomatic transmission

Vaccines 122

Vaccines 122

NY Times

FEBRUARY 3, 2021

The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.

124

124

Outsourcing Pharma

FEBRUARY 4, 2021

The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm's tech and patient-centric approach.

115

115

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

FEBRUARY 4, 2021

For World Cancer Day, David Long, business unit director of Oncology at MSD UK tells pharmaphorum about the company’s ‘Do It Yourself’ campaign launched in the North East to raise awareness of lung cancer symptoms. As COVID cases surged last year, lung cancer referrals dropped in the UK, causing alarm to the UK Lung Cancer Coalition (UKLCC), an alliance of the UK’s leading lung cancer experts, senior NHS professionals, charities, and healthcare companies.

Chemotherapy 133

Chemotherapy Compounding 133

Drug Patent Watch

FEBRUARY 2, 2021

DrugPatentWatch was featured in a recent article by Inc. Magazine. In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…. The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions.

Drug Pricing 103

Drug Pricing 103

Pharma Times

FEBRUARY 3, 2021

Final guidance on the drug's use to treat patients with severe eosinophilic asthma on the NHS has now been published

119

119

pharmaphorum

FEBRUARY 5, 2021

Over the last year, we’ve noticed that “connectivity” doesn’t always equate to “connected” – and that’s just as true in the realm of clinical trials as it is in our personal lives. Amanda Barrell reports from a panel at the Patients as Partners Europe conference on remote clinical trials. Decentralised trials have been growing in popularity in recent years, and the COVID-19 pandemic has served to accelerate that progress.

Hospitals 132

Hospitals Communication 132

Pharma Marketing Network

FEBRUARY 4, 2021

Moderator and Panelists: Amy Turnquist , EVP, Digital, eHealthcare Solutions (Moderator). Ryan Billings , U.S. Oncology Digital Marketing & Customer Experience at GSK. Desiree Priestley , Director, Patient Support Strategy & Insights at Otsuka America Pharmaceutical. Kristen Palmer Winters , Customer Experience (CX), Americas Hub, Digital & Commercial Innovation, Bayer.

98

98

Drug Patent Watch

FEBRUARY 3, 2021

This article was originally published by Ioana Gherghescu and Begoña Delgado-Charro in Pharmaceutics 2021, 13(1) under a Creative Commons Attribution License. Abstract Biosimilar medicines expand the biotherapeutic market and improve…. The post The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA appeared first on DrugPatentWatch - Make Better Decisions.

Biosimilars 98

Biosimilars 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

FEBRUARY 4, 2021

An Oxford University trial, a world first, is looking at whether inoculating volunteers with doses of different combinations of two currently approved COVID-19 vaccines is effective.

Vaccines 93

Vaccines 93

pharmaphorum

FEBRUARY 1, 2021

It’s well recognised that people with psoriasis can develop depression or anxiety, particularly in moderate or severe cases where a sizeable part of the body can have skin lesions. Now, drugmaker Almirall and digital health firm Happify are working on a tool to support mental health in these patients. Almirall is a specialist in psoriasis therapies with drugs like Skilarence (dimethyl fumarate) and Ilumetri (tildrakizumab), while Happify’s app is designed to drive away negative thoughts through

122

122

Pharma Times

FEBRUARY 1, 2021

Research led by the University of East Anglia in collaboration Boots UK and Leiden University

122

122

NY Times

JANUARY 30, 2021

Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.

Vaccines 91

Vaccines 91

Outsourcing Pharma

FEBRUARY 4, 2021

A report from the World Economic Forum and Lung Ambition Alliance outlines the impacts the pandemic is having on lung cancer diagnoses and treatment.

98

98

pharmaphorum

FEBRUARY 1, 2021

The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses. At the end of last week, the European Commission was forced into an embarrassing U-Turn when it tried to impose restrictions on COVID-19 vaccines exported from the bloc.

Vaccines 108

Vaccines 108

Pharma Times

FEBRUARY 3, 2021

The MHRA has issued a positive scientific opinion for abrocitinib allowing its use via the early access to medicines scheme (EAMS)

94

94

NY Times

FEBRUARY 5, 2021

No drug could touch a quivering protein implicated in a variety of tumors. Then one chemist saw an opening.

104

104

Outsourcing Pharma

FEBRUARY 1, 2021

The panel is intended to address ethical matters that arise around evolving data and digital conduct for all of its various business sectors.

90

90

pharmaphorum

FEBRUARY 3, 2021

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in 2018, according to the latest BioIndustry Association (BIA) and Clarivate report, and represents a 1,000% increase on 2012.

Vaccines 107

Vaccines Drug Development 107

Pharma Times

FEBRUARY 4, 2021

Projects will investigate immune checkpoints and contribute to the development of new cancer treatments

Immunity 105

Immunity Immunization 105

Drug Patent Watch

FEBRUARY 3, 2021

Annual Drug Patent Expirations for DSUVIA Dsuvia is a drug marketed by Acelrx Pharms and is included in one NDA. It is available from one supplier. There are seventeen patents…. The post New patent for Acelrx Pharms drug DSUVIA appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Outsourcing Pharma

FEBRUARY 1, 2021

The firms will work to develop solutions centered on increasing diversity and inclusivity in clinical research, and addressing healthcare disparities.

83

83

pharmaphorum

FEBRUARY 4, 2021

By Jennifer Mercer , CEO of Metazoa. Jennifer Mercer is Co-founder and CEO of Metazoa, developers of Snapshot, an admin and developer tool for companies with complex Salesforce orgs that is used by over 60% of Fortune 100 companies. . Salesforce org management is usually not the headliner for CIOs and CTOs looking to catch up on executive-level trends and issues pertaining to technology.

Documentation 104

Documentation 104

Pharma Times

FEBRUARY 1, 2021

Bumper meeting saw 13 new medicines recommended for approval

124

124

NY Times

FEBRUARY 1, 2021

Ursula von der Leyen has largely stayed away from the limelight while driving the handling of a crisis and letting subordinates take the blame.

Vaccines 63

Vaccines Immunity Immunization 63

Outsourcing Pharma

FEBRUARY 4, 2021

William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.

77

77

pharmaphorum

FEBRUARY 3, 2021

NICE has recommended regular NHS funding for Novartis’ long-acting eye drug Beovu (brolucizumab) in England and Wales – but a patient group warned that access could be limited until the pandemic recedes because of disruption to ophthalmology clinics. In final guidance NICE said trials have shown Novartis’ Beovu has similar efficacy in wet advanced macular degeneration (AMD) to rival Eylea (aflibercept) from Bayer/Regeneron and Novartis predecessor Lucentis (ranibizumab).

Labelling 98

Labelling Hospitals 98

Pharma Times

FEBRUARY 5, 2021

Immunotherapy recommended for patients with or without PD-L1 tumour expression

105

105

NY Times

FEBRUARY 2, 2021

Mientras las regiones con más recursos compran vacunas, otras podrían convertirse en caldo de cultivo de mutaciones que podrían hacer que las vacunas en general fueran menos eficaces.

Immunity 54

Immunity Immunization Vaccines 54

Drug Patent Watch

FEBRUARY 5, 2021

Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are fifty-nine patents…. The post New patent for Amarin Pharms drug VASCEPA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

FEBRUARY 1, 2021

Novartis’ multiple sclerosis drug has been given the green light by the European Medicines Agency’s CHMP scientific committee, paving the way for a likely approval in the coming weeks. Kesimpta (ofatumumab) started life as an oncology drug and was first developed by Genmab and licensed to GlaxoSmithKline who marketed under the brand name Arzerra to treat chronic lymphocytic leukaemia.

97

97

Pharma Times

FEBRUARY 2, 2021

European Commission has authorised treatment for uncontrolled asthma patients

111

111

NY Times

FEBRUARY 5, 2021

El desarrollo de las vacunas superó las expectativas de todos. Pero durante los próximos meses muchas personas enfermarán y, lamentablemente, los médicos tienen pocos fármacos para tratarlas.

Immunity 54

Immunity Immunization Vaccines 54

Drug Patent Watch

FEBRUARY 5, 2021

Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.

52

52